Thank you for subscribing!
Finfeed Archived May 18, 2020
After a rollercoaster week, a 76 point gain was enough to drag the S&P/ASX 200 (XJO) back into the black. Overseas markets were generally less volatile on Friday, albeit not making the substantial gains. However, it could be argued that market stability is a better sign than the extreme highs and lows that have set the tone in recent months.
Finfeed Archived May 14, 2020
While the ASX dug itself out of a hole yesterday, it is unlikely that investors will brush off the news that US markets plunged more than 500 points overnight.
Finfeed Archived May 12, 2020
The S&P/ASX 200 finished up 1.3% to close at 5461 points on Monday. With mixed to negative leads coming from overseas last night some profit-taking would surprise.
Finfeed Archived May 08, 2020
Wall Street’s indexes climbed on Thursday, with the Nasdaq erasing losses for 2020, following a clutch of upbeat earnings reports led by PayPal.
Get expert stock analysis direct in your inbox
Finfeed Archived May 01, 2020
According to many surveys conducted by the ASX, it is common to find around 50 per cent of adult Australians believe they are very knowledgeable or somewhat knowledgeable when it comes to investing in shares. Are they overestimating their abilities?
Finfeed Archived Apr 30, 2020
The ASX looks set for another strong performance today after the S&P/ASX 200 increased 1.5% on Wednesday. With good news all round, it is not surprising to see that the ASX SPI200 up 108, indicating the ASX is in for a good day.
Finfeed Archived Apr 16, 2020
Don’t be lured into the ‘Bear Market Trap’ and perceived honey pot of gains to be had just because the market has risen like a soufflé in the past few weeks.
Finfeed Archived Mar 25, 2020
While the Australian stock market responded positively to the strong lead from Wall Street after the Dow surged more than 2000 points or 11% overnight, the gains were nowhere near those experienced in the US.
Finfeed Archived Feb 27, 2020
The coming 12 months is shaping up as a watershed stage in the history of Oncosil Medical Ltd (ASX:OSL) as it flags the finalisation of commercialisation plans for its OncoSil™ device ahead of CE marking early in 2020.
Join Our Mailing List